Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OOutlook Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

Outlook Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 1, 2026Lundquist Kevin MichaelChief Financial Officer500,000Employee Stock Option (Right to Buy)$320KGrant / award
Aug 14, 2026Jahr Robert CharlesChief Executive Officer151,515Warrants (right to buy)$115.2KBuy
Aug 14, 2026Jahr Robert CharlesChief Executive Officer151,515Common Stock$115.2KBuy
Aug 14, 2026KENYON LAWRENCE AChief Financial Officer101,010Warrants (right to buy)$76.8KBuy
Aug 14, 2026KENYON LAWRENCE AChief Financial Officer101,010Common Stock$76.8KBuy
Aug 12, 2026Sukhtian Ghiath M.Director, 10% Owner2,525,252Warrants (right to buy)$2.6MBuy
Aug 12, 2026Sukhtian Ghiath M.Director, 10% Owner2,525,252Common Stock$2.6MBuy
Jul 29, 2026Sukhtian Faisal GhiathDirector95,398Common Stock$134.5KBuy
Jul 21, 2026Jahr Robert CharlesChief Executive Officer100,000Stock Option (Right to Buy)$139KGrant / award
Jul 21, 2026KENYON LAWRENCE AChief Financial Officer210,078Stock Option (Right to Buy)$292KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.70Close · Sep 22, 2026